Max Healthcare Institute LtdQ1 FY26
Max Healthcare Institute Ltd Q1 FY26 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹1,081P/E: 70.0Market Cap: ₹1.0L CrSector: Healthcare Services
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →Phased commissioning of 20% additional brownfield capacity across Mohali, Nanavati (Mumbai), and Max Smart (Delhi) completed; full operationalization expected in next 2-3 months.
- →Additional 10% capacity to come from 500-bed greenfield hospital in Gurgaon, targeted for commissioning by end of the year.
- →Brownfield bed additions expected to ramp up EBITDA contribution meaningfully over next 2 quarters as occupancy rises.
- →Network gross revenue grew 16% YoY to INR 10,538 crore in FY26; operating EBITDA up 14% YoY.
- →Oncology revenue impacted by discontinuation of select high-value chemotherapy drugs; oncology share expected to stabilize around 21-22%, with other specialties expected to fill growth gap.
- →Occupancy levels remain strong (>75%) with phased bed rollouts to continue, supporting steady revenue and EBITDA growth.
- →New acquisitions like Kalinga Hospital to provide growth platforms in new regions (Eastern India).
- →Focus on ramping up recently commissioned capacities and integrating new facilities for sustained growth.
Margin guidance
Category 3- →Max Healthcare expects significant operating leverage as recently added 20-25% brownfield capacity and upcoming greenfield projects ramp up over next 2-3 quarters to FY27.
- →The 500-bed greenfield hospital in Gurgaon is targeted for commissioning by end of FY27, expected to break even within first year.
- →New acquisitions like Kalinga Hospital (already EBITDA positive at INR 10 crore) and expansion in Lucknow, Dwarka, Noida are anticipated to contribute meaningfully to revenue and EBITDA growth.
- →The company has sustained 8-16% revenue growth and 8-14% operating EBITDA growth in recent quarters/years.
- →Profit after Tax (PAT) grew 22% in FY26, reflecting robust profitability.
- →Continued ramp-up and integration of newly commissioned beds and new facilities should support steady earnings growth and EPS expansion.
- →No significant regulatory or approval delays expected for pipeline projects, supporting timely execution and earnings contribution.
3 more insights locked — sign up free to unlock
Fundraise plans
- →The transcript provided from Max Healthcare Institute Limited's Q4 & FY’26 earnings call does not mention any current or planned fundraising through debt or equity.
- →There is no indication of new debt issuance or equity raising activities discussed in the management commentary or Q&A sections.
- →The company notes strong free cash flow generation (INR 1,541 crore in FY26 after interest and taxes) and significant internal capital deployment towards expansion projects.
- →Net debt has decreased from INR 2,166 crore to INR 1,908 crore, showing a healthy deleveraging trend.
- →Management appears focused on phased expansion funded via internal accruals rather than external fundraising at this time.
Order book
- →Max Healthcare has multiple ongoing and planned expansion projects with phased commissioning timelines.
- →Current expansion includes nearly 20% additional brownfield capacity added network-wide.
- →Specific projects and timelines:
- → - Max Lucknow: Capacity increasing from 426 to 570 beds in next 2 quarters.
- → - Sector 56 Gurgaon: 500 beds, commissioning targeted by end of FY 2026.
- → - Max Nagpur: 100 beds, expected commissioning by FY 2028.
- → - Zirakpur, Mohali: 400 beds, structural work ongoing, commissioning in FY 2028.
- → - Max Dwarka: 260 beds, building plan underway, 24 months to complete.
- → - Max Vaishali: 200 beds, pending building approvals, expected 24 months post approvals.
- → - Max Patparganj: 400 beds, construction started, commissioning by FY 2029.
- → - Shaheed Path Greenfield Hospital, Lucknow: 700 beds, INR 1,400 crore investment approved; phased build over ~3 years.
- →Overall strategy involves phased operationalization to manage ramp-up and occupancy efficiently.
Capex plans
Yes- →The Board has approved an investment of INR 1,400 crore for constructing a 700-bed greenfield hospital at Shaheed Path, Lucknow.
- →Expansion projects underway include:
- → - Max Lucknow capacity increase from 426 to 570 beds over next 2 quarters.
- → - 500-bed facility at Sector 56 Gurgaon, commissioning targeted by end of the year.
- → - 100 beds at Max Nagpur, expected commissioning by FY28.
- → - 400 beds at Zirakpur, Mohali, on schedule for FY28.
- → - 260 beds at Max Dwarka, building plan submission underway, expected 24 months to complete.
- → - 200 beds at Max Vaishali, awaiting building plan approvals, 24 months expected post-approval.
- → - 400 beds at Max Patparganj, D-wall construction started, expected commissioning by FY29.
- →Ongoing phased commissioning of over 20% additional brownfield capacity across hospitals.
- →Acquisition and expansion plans for Kalinga Hospital (250 beds) in Bhubaneswar.
How does Max Healthcare Institute Ltd rank vs peers in Healthcare Services?
Pro feature1Max Healthcare Institute Ltd
Rev 3Mar 3
See full Healthcare Services sector rankings
Want more stocks like Max Healthcare Institute Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio